To evaluate the role of DNAJA2 in glucose metabolic disorders, we first analyzed DNAJA2 expression levels from a published dataset (GSE2572425) in human islets isolated from T2DM patients and non-diabetic individuals. This evidence concerns the gene DNAJA2 and glucose metabolism disease.